Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Galleri is the first of a wave of multi-cancer early-detection tests that analyze DNA fragments in the blood for abnormalities.
Risk-based testing alone has failed to identify a majority of people living with chronic HBV.
Patients whose treatment was guided by measurement of tumor cells in the blood had improved survival outcomes.
Testing advances made during the COVID-19 pandemic may lead to “test and treat” approaches for hepatitis C. But there’s a holdup.
Tests like the one approved this week can show who is likely to be immune, but it’s not yet clear how long such immunity lasts.
Many people with GI cancers are diagnosed only after the disease has spread through the body, so this test could aid in early detection.
The test was able to identify many cancers, and their location, at early stages.
In a study, the often mis- or undiagnosed illness was successfully differentiated from related diseases.
A high-sensitivity blood test will allow patients feeling chest pains to learn almost immediately whether they’re having a heart attack.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.